A Study of Single Dose of BL0175 in Postmenopausal Women

NCT07366632 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Postmenopausal Women

Interventions

DRUG: BL0175
DRUG: Fulvestrant

Sponsor

Shanghai Best-Link Bioscience, LLC